Skip to main content
Premium Trial:

Request an Annual Quote

Quanta, IDT Sign Deal for Manufacture of microRNA Assays

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Quanta BioSciences today announced a partnership with Integrated DNA Technologies for the manufacture of assays for quantifying microRNAs.

Under the terms of the deal, IDT will produce the assays and market them through an online catalog directly to customers of Quanta.

Financial and other terms of the deal were not disclosed.

Based in Gaithersburg, Md., Quanta develops reagents for PCR, qPCR, and cDNA applications.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more